A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
Phase 4
Completed
- Conditions
- Parkinsonian Syndromes
- Interventions
- Procedure: DaTSCAN SPECT imaging
- First Posted Date
- 2006-10-02
- Last Posted Date
- 2012-09-03
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 273
- Registration Number
- NCT00382967
- Locations
- 🇫🇷
GE Healthcare, Velizy, France
Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: Technetium Tc99m Tetrofosmin injections
- First Posted Date
- 2006-09-27
- Last Posted Date
- 2007-12-05
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 291
- Registration Number
- NCT00381316
- Locations
- 🇺🇸
GE Healthcare, Princeton, New Jersey, United States
A Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT
Not Applicable
Terminated
- Conditions
- Coronary Artery Disease
- Interventions
- Device: 64 Channel VCT
- First Posted Date
- 2006-07-10
- Last Posted Date
- 2019-04-30
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 77
- Registration Number
- NCT00350506
- Locations
- 🇺🇸
GE Healthcare, Princeton, New Jersey, United States
Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2019-04-25
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 66
- Registration Number
- NCT00348608
A Study of Computed Tomography (CT) for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest Pain
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: 64 Channel VCT
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 245
- Registration Number
- NCT00348569
- Locations
- 🇺🇸
Robert Centofanti, MS, Princeton, New Jersey, United States
Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart
- First Posted Date
- 2006-06-09
- Last Posted Date
- 2019-04-25
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 89
- Registration Number
- NCT00335335
Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography
Phase 4
Withdrawn
- Conditions
- Coronary Artery Disease (CAD)Renal ImpairmentDiabetes Mellitus
- First Posted Date
- 2006-06-08
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- GE Healthcare
- Registration Number
- NCT00335101
- Locations
- 🇩🇪
GE Healthcare, Munich, Germany
A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide
Phase 3
Completed
- Conditions
- Aorto-iliac StenosisArterial Occlusive Diseases
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2019-04-25
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 407
- Registration Number
- NCT00209443
- Locations
- 🇩🇪
Amersham Buchler GmbH & Co. KG, Ismaning, Germany
Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography
Phase 4
Terminated
- Conditions
- Renal InsufficiencyDiabetes Mellitus
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2014-10-17
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 656
- Registration Number
- NCT00209417
- Locations
- 🇬🇧
GE Healthcare, Amersham, United Kingdom
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Phase 3
Completed
- Conditions
- Lewy Body DementiaNon-DLB DementiaAlzheimer'sVascular Dementia
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-05-16
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 326
- Registration Number
- NCT00209456
- Locations
- 🇩🇪
Amersham Buchler GmbH Co. KG, Ismaning, Germany
© Copyright 2025. All Rights Reserved by MedPath